SCHEMBL21775441

SCHEMBL21775441

CSc1c(C)nc2cc(-c3ccc(F)cc3F)nn2c1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.38
PDE10A Q9Y233 1/20 0.36
TSHR P16473 2/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
F2RL3 Q96RI0 1/20 0.35
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 2/20 0.34
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34
GRM5 P41594 1/20 0.34
KMO O15229 1/20 0.34
GLA P06280 1/20 0.34
MAPT P10636 4/20 0.33
HSD17B10 Q99714 1/20 0.33
TP53 P04637 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4D Q08499 1/20 0.33
CHRM2 P08172 1/20 0.33
PRKD3 O94806 1/20 0.33
MAP4K4 O95819 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21774084 0.88 DPP4 (0.42) ALDH1A1KMOTP53NPC1RAB9A
SCHEMBL21775859 0.87 KDM4E (0.40) THRBPDE10AKDM4EALDH1A1POLB
SCHEMBL21775440 0.86 MPL (0.39) KDM4EALDH1A1MAPTHSD17B10TP53
SCHEMBL21775726 0.80 NPC1 (0.41) TSHRABCG2KDM4EALDH1A1GAA
SCHEMBL21775466 0.79 DPP4 (0.51) NPC1RAB9A
SCHEMBL21775437 0.77 DPP4 (0.49) THRBPDE10AKDM4EALDH1A1POLB
SCHEMBL21775434 0.77 DPP4 (0.38) ABCG2KDM4EALDH1A1MAPTTP53
SCHEMBL21749203 0.75 NPC1 (0.57) KDM4EALDH1A1GAAMAPTHSD17B10
SCHEMBL21775461 0.75 NPC1 (0.46) KDM4EALDH1A1POLBMAPTHSD17B10
SCHEMBL21775475 0.75 EGLN2 (0.41) KDM4EALDH1A1GAAMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives RICHTER GEDEON NYRT. (HU) 2021-03-30 US disclosed
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives RICHTER GEDEON NYRT. (HU) 2020-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives GABRA5, P2RX5, P2RY1 THRB 312/4885PDE10A 299/4885TSHR 698/4885
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives GABRA5, P2RX5, P2RY1 THRB 312/4885PDE10A 299/4885TSHR 698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.